Charles M Gerrits
Affiliation: Takeda Global Research and Development Center
- A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetesCharles M Gerrits
Department of Global Pharmacoepidemiology, Takeda Global Research and Development, Inc, Deerfield, IL, USA
Pharmacoepidemiol Drug Saf 16:1065-71. 2007..Recent studies have raised concerns about potential increased cardiovascular (CV) risk in type 2 diabetes patients treated with some peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonists...